✦ LIBER ✦

A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer

✍ Scribed by David H. Johnson; John C. Ruckdeschel; James H. Keller; Gary H. Lyman; Gerald J. Kallas; John Macdonald; Ronald C. Deconti; Jeannette Lee; Q. Scott Ringenberg; William P. Patterson; Hillard M. Lazarus; Jacob Lokich

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 501 KB
Volume: 67
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19910101)67:1+<245::aid-cncr2820671306>3.0.co;2-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of cisplatin and prolon

A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancer

✍ Patrick B. Murphy; John D. Hainsworth; F. Anthony Greco; Kenneth R. Hande; Russe 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

Etoposide versus etoposide plus high-dos

Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer: Results of a prospective randomized fonicap trial

✍ Professor Riccardo Rosso; Franco Salvati; Andrea Ardizzoni; Corrado Gallo Curcio 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

The addition of cisplatin to cyclophosph

The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma : A randomized study of 457 patients

✍ Thierry Urban; Claude Chastang; François-Xavier Lebas; Jean-Paul Duhamel; Guy Ad 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## BACKGROUND. To assess whether the addition of cisplatin (100 mg/m 2 administered intravenously on Day 1) to CDE (cyclophosphamide [1000 mg/m 2 on Day 1], doxorubicin [45 mg/m 2 on Day 1], and etoposide [150 mg/m 2 on Days 1 and 2] combination is useful in the treatment of patients with small cel

Combination chemotherapy with mitomycin-

Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer

✍ Niell, Harvey B. ;Griffin, John P. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

The drug combination of mitomycin-C, cisplatin, and vinblastine was administered to 30 patients with stage III non-small-cell lung cancer. All patients had a performance status of 50% or greater, had evaluable disease, and had not received previous chemotherapy. The overall response rate was 37% wit

Combination chemotherapy with mitomycin

Combination chemotherapy with mitomycin C, methotrexate, cisplatin, and vinblastine in the treatment of non-small cell lung cancer

✍ Harvey B. Niell; John P. Griffin; William H. West; Charles L. Neely 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 2 views

The effect of intravenous hyperalimentat

The effect of intravenous hyperalimentation on the dietary intake of patients with small cell lung cancer. A randomized trial

✍ Gerald Clamon; Lilly Gardner; David Pee; Phyllis Stumbo; Ronald Feld; William Ev 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 590 KB

In a randomized trial of 119 patients with small cell cancer of the lung, the effects of a 30-day course of central intravenous hyperalimentation (IVH) on dietary intake were evaluated. All patients underwent the same aggressive chemotherapy and radiation therapy; 57 patients received IVH and 62 ser